Immunotherapy Promising for Diabetes: Study | The Scientist Magazine®

In new ground-breaking research The Scientist Magazine, reports on a small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.

Source: Immunotherapy Promising for Diabetes: Study | The Scientist Magazine®

This is very much early research but if all goes well the drug could be on the market in five to ten years time. At the moment, those with Type 1 Diabetes must take insulin injections.

Thoughts?

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: